Investors locked in profits on Fate Therapeutics Inc. (Nasdaq: FATE). The stock price lost 55 cents to close at $6.09.
Profit taking weighs down Fate Therapeutics
December 28, 2017 at 17:49 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|